Development of nanostructured lipid carriers for controlled delivery of mefenamic acid

International Journal of Biomedical Nanoscience and Nanotechnology

Volumn 2, Issue 3-4, 2012, Pages 232-250

  Khurana, Shelly ^a   Bedi, P M S ^a   Jain, N K ^b  

^a GURU NANAK DEV UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

CA; caprylic acid; cetyl palmitate; CI; CP; crystallinity index; mefenamic acid; MFA; nanostructured lipid carriers; NLCs; occlusion factor

Indexed keywords

EID: 84874109554     PISSN: 17560799     EISSN: 17560802     Source Type: Journal    
DOI: 10.1504/IJBNN.2012.051218     Document Type: Article

References (46)

1. Ali, H., El-Sayed, K., Sylvester, P.W. and Nazzal, S. (2010) ‘Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: Evidence studies by differential scanning calorimetry (DSC) and proton nuclear magnetic resonance spectroscopy (1H NMR)’, Colloids and Surfaces B: Biointerfaces, Vol. 77, No. 2, pp.286–297.
2. Bunjes, H. and Koch, M.H.J. (2005) ‘Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles’, J. Control. Release, Vol. 107, No. 2, pp.229–243.
3. Bunjes, H., Westesen, K. and Koch, M.H.J. (1996) ‘Crystallization tendency and polymorphic transitions in triglycerides nanoparticles’, Int. J. Pharm., Vol. 129, Nos. 1–2, pp.159–173.
4. Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H. and Yang, X. (2006) ‘Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting’, J. Control. Release, Vol. 110, No. 2, pp.296–306.
5. Cui, Z. and Mumper, R.J. (2002) ‘Genetic immunization using nanoparticles engineered from microemulsion precursors’, Pharm. Res., Vol. 19, No. 7, pp.939–946.
6. Cui, Z., Hsu, C-H. and Mumper, R.J. (2003) ‘Physical characterization and macrophage cell uptake of mannan-coated nanoparticles’, Drug Dev Ind Pharm., Vol. 29, No. 6, pp.689–700.
7. Dai, W., Zhang, D., Duan, C., Jia, L., Wang, Y., Feng, F. and Zhang, Q. (2010) ‘Preparation and characteristics of oridonin-loaded nano structured lipid carriers as a controlled-release’, Journal of Microencapsulation, Vol. 27, No. 3, pp.234–241.
8. De Vringer, T. and De Ronde, H.A.G. (1995) ‘Preparation and structure of a water-in-oil cream containing lipid nanoparticles’, J. Pharm. Sci., Vol. 84, No. 4, pp.466–472.
9. Doktorovovaa, S., Araujob, J., Garciab, M.L., Rakovsky, E. and Souto, E.B. (2010). ‘Formulating fluticasone propionate in novel PEG-containing nano structured lipid carriers (PEG-NLC)’, Colloids and Surfaces B: Biointerfaces, Vol. 75, No. 2, pp.538–542.
10. Garcia-Fuentes, M., Alonso, M.J. and Torres, D. (2005) ‘Design and characterization of a new rug nanocarrier made from solid-liquid lipid mixtures’, J. Colloid Interface Sci., Vol. 285, No. 2, pp.590–598.
11. Gonzalez-Mira, E., Nikolic, S., García, M.L., Egea, M.A., Souto, E.B. and Calpena, A.C. (2011) ‘Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen’, J. Pharm Sci., Vol. 100, No. 1, pp.242–251.
12. Han, F., Li, S., Yin, R., Liu, H. and Xu, L. (2008) ‘Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers’, Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 315, Nos. 1–3, pp.210–216.
13. Higuchi, W.I. (1962) ‘Analysis of data on the medication release from ointments’, J. Pharm. Sci., Vol. 51, No. 8, pp.802–804.
14. Jackson, C.L. and McKenna, G.B. (1990) ‘The melting behavior of organic materials confined in porous solids’, J. Chem. Phys., Vol. 93, No. 12, pp.9002–9011.
15. Jenning, V., Thunemann, A.F. and Gohla, S.H. (2000) ‘Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids’, Int. J. Pharm. Vol. 199, No. 2, pp.167–177.
16. Junyaprasert, V.B., Teeranachaideekul, V., Souto, E.B., Boonme, P. and Muller, R.H. (2009) ‘Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation’, Int. J. Pharm., Vol. 377, Nos. 1–2, pp.207–214.
17. Khurana, S., Bedi, P.M.S. and Jain, N.K. (2010) ‘Development of nanostructured lipid carriers (NLC) for controlled delivery of meloxicam’, Int. J. Biomedical Nanoscience and Nanotechnology, Vol. 1, Nos. 2/3/4, pp.247–266.
18. Khurana, S., Utreja, P., Tiwary, A.K., Jain, N.K. and Jain, S. (2009) ‘Nanostructured lipid carriers and their application in drug delivery’, Int. J. Biomedical Engineering and Technology, Vol. 2, No. 2, pp.152–171.
19. Lacerda, S.P., Cerize, N.N.P. and Re, M.I. (2011) ‘Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone-3’, International Journal of Cosmetic Science, Vol. 33, No. 4, pp.312–321.
20. Lim, S.J. and Kim, C.K. (2002) ‘Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid’, Int. J. Pharm., Vol. 243, Nos. 1–2, pp.135–146.
21. Lin, X., Li, X., Zheng, L., Yu, L., Zhang, Q. and Liu, W. (2007) ‘Preparation and characterization of monocaprate nanostructured lipid carriers’, J. Colloid Interface Sci., Vol. 311, Nos. 1–3, pp.106–111.
22. Mehnert, W. and Mader, K. (2001) ‘Solid lipid nanoparticles: production, characterization and applications’, Adv. Drug Deliv. Rev., Vol. 47, No. 2, pp.165–196.
23. Muller, R.H., Lucks, J.S., Schwarz, C., Zur Muhlen, A., Weyhers, H., Freitas, C. and Ruhl, D. (1995) ‘Solid lipid nanoparticles (SLN) – an alternative colloidal carrier system for controlled drug delivery’, Eur. J. Pharm. Biopham., Vol. 41, No. 1, pp.62–69.
24. Muller, R.H., Mader, K. and Gohla, S. (2000) ‘Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art’, Eur. J. Pharm. Biopharm., Vol.50, No. 1, pp.161–177.
25. Muller, R.H., Radtke, M. and Wissing, S.A. (2002a) ‘Nanostructured lipid matrices for improved microencapsulation of drugs’, Int. J. Pham., Vol. 242, Nos. 1–2, pp.121–128.
26. Muller, R.H., Radtke, M. and Wissing, S.A. (2002b) ‘Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations’, Adv. Drug Deliv. Rev., Vol. 54, No. 1, pp.S131–155.
27. Oyewumi, M.O. and Mumper, R.J. (2002) ‘Gadolinium-loaded nanoparticles engineered from microemulsion templates’, Drug Dev. Ind. Pham., Vol. 28, No. 3, pp.317–328.
28. Oyewumi, M.O. and Mumper, R.J. (2003) ‘Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles’, Int. J. Pham., Vol. 251, Nos. 1–2, pp.85–97.
29. Park, S.H. and Choi, H.K. (2006) ‘The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs’, Int. J. Pham., Vol. 321, Nos. 1–2, pp.35–41.
30. Patlolla, R.R., Chougule, M., Patel, A.R., Jackson, T., Tata, P.N. and Singh, M. (2010) ‘Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers’, J. Control. Release, Vol. 144, No. 2, pp.233–241.
31. Saupe, A., Gordon, K.C. and Rades, T. (2006) ‘Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy’, Int. J. Pham., Vol. 314, No. 1, pp.56–62.
32. Saupe, A., Wissing, S.A., Lenk, A., Schmidt, C. and Muller, R.H. (2005) ‘Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) – structural investigations on two different carrier systems’, Biomed. Mater. Eng., Vol. 15, No. 5, pp.393–402.
33. Souto, E.B. and Muller, R.H. (2008) ‘Cosmetic features and applications of lipid nanoparticles (SLN, NLC)’, International Journal of Cosmetic Science, Vol. 30, No. 3, pp.157–165.
34. Teeranachaideekul, V., Boonme, P., Souto, E.B., Muller, R.H. and Junyaprasert, V.B. (2008) ‘Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC’, J. Control. Release, Vol. 128, No. 2, pp.134–141.
35. Teeranachaideekul, V., Souto, E.B., Junyaprasert, V.B. and Muller, R.H. (2007) ‘Cetyl palmitate-based NLC for topical delivery of coenzyme Q 10-development, physicochemical characterization and in vitro release studies’, Eur. J. Pham. Biopahm., Vol. 67, No. 1, pp.141–148.
36. Uner, M. and Yener, G. (2007) ‘Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives’, Int. J. Nanomedicine, Vol. 2, No. 3, pp.289–300.
37. Utreja, S. and Jain, N.K. (2001) ‘Solid lipid nanoparticles’, in Jain, N.K. (Ed.): Advances in Controlled and Novel Drug Delivery, pp.408–425, CBS Publishers and Distributors, New Delhi, India.
38. Wang, J.J., Liu, K.S., Sung, K.C., Tsai, C.Y. and Fang, J.Y. (2009) ‘Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection’, Eur. J. Pham. Sci., Vol. 38, No. 2, pp.138–146.
39. Wang, J.X., Sun, X. and Zhang, Z.R. (2002) ‘Enhanced brain targeting by synthesis of 3’, 5’-dioctanoyl-5-fluoro-2’-deoxyuridine and incorporation into solid lipid nanoparticles’, Eur. J. Pham. Biopharm., Vol. 54, No. 3, pp.285–290.
40. Washington, C. (1989) ‘Evaluation of the non-sink dialysis method for the measurement of drug release from colloids effect of drug partition’, Int. J. Pham., Vol. 56, No. 1, pp.71–74.
41. Wissing, S.A. and Muller, R.H. (2003) ‘The influence of solid lipid nanoparticles on skin hydration and viscoelasticity – in vivo study’, Eur. J. Pham. Biopahm., Vol. 56, No. 1, pp.67–72.
42. Yang, S.C., Lu, L.F., Cai, Y., Zhu, J.B., Liang, B.W. and Yang, C.Z. (1999) ‘Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain’, J. Control. Release, Vol. 59, No. 3, pp. 299–307.
43. Zhang, X., Liu, J., Qiao, H., Liu, H., Ni, J., Zhang, W. and Shi, Y. (2010) ‘Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology’, Powder Technology, Vol. 197, Nos. 1–2, pp. 120–128.
44. Zhang, X.G., Miao, J., Dai, Y.Q., Du, Y.Z., Yuan, H. and Hu, F.Q. (2008) ‘Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells’, Int. J. Pharm., Vol. 361, Nos. 1–2, pp.239–244.
45. Zimmermann, E., Souto, E.B. and Muller, R.H. (2005) ‘Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR’, Pharmazie, Vol. 60, No. 7, pp.508–513.
46. Zur Muhlen, A., Schwarz, C. and Mehnert, W. (1998) ‘Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism’, Eur. J. Pharm. Biopharm., Vol. 45, No. 2, pp.149–155.